Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 4:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 1,441 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Measurement Clear all

Conditions: Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents
Interventions: TAK-935, [18F]MNI-792 (tracer); Drug
Lead sponsor: Takeda; Industry
Eligibility: 19 Years to 55 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Osteopenia Of Prematurity
Interventions: Ultrasound machine; Device
Lead sponsor: University of South Florida; Other
Eligibility: 24 Weeks to 33 Weeks
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Irradiation; Adverse Effect
Interventions: Standard of care given for treatment of cancer; Radiation
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Stroke
Interventions: Breathing Exercise; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 99 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Upper GI Bleeding
Interventions: HemoPill acute; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 22 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Hypoxemia, Hypoxia
Interventions: Non-Contact Oximetry; Device
Lead sponsor: University of Virginia; Other
Eligibility: Up to 12 Months
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Sickle Cell Disease
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Abdominal Surgery
Interventions: Not listed
Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre; Other
Eligibility: 18 Years and older
Enrollment: 530 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2026
U.S. locations: 2
States / cities: Weston, Florida • Cleveland, Ohio

Conditions: Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: OSA, Sleep Apnea
Interventions: Mandible slacked and captured with Correct Plus™ Impression Material Superfast; Procedure
Lead sponsor: Manhattan Beach Orthodontics; Other
Eligibility: Not listed
Enrollment: 6 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Manhattan Beach, California

Conditions: Photodynamic Therapy, Protoporphyrin IX
Interventions: Portable Apple Smart Phone Protoporphyrin IX Spectrometer Camera; Device
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 219 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: CHD - Congenital Heart Disease, Single Ventricle Heart Disease
Interventions: vital sign monitoring; Device
Lead sponsor: Le Bonheur Children's Hospital; Other
Eligibility: 0 Months to 12 Months
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: IV Infiltration, IV Extravasation
Interventions: non-invasive thermal infusion site monitoring NTISM device; Device
Lead sponsor: Rhaeos, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: Biogen; Industry
Eligibility: 21 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 3
States / cities: Baltimore, Maryland • New York, New York • Cleveland, Ohio

Conditions: Pseudoaphakia
Interventions: Ophthalmic Biometer; Device
Lead sponsor: Haag Streit USA; Industry
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Infertility
Interventions: Not listed
Lead sponsor: Boston IVF; Other
Eligibility: Female only
Enrollment: 335 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2017
U.S. locations: 8
States / cities: Pasadena, California • Atlanta, Georgia • Chicago, Illinois + 5 more

Conditions: Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Chronic Bronchitis
Interventions: Salmeterol or Salmeterol/Fluticasone; Drug
Lead sponsor: National Jewish Health; Other
Eligibility: 40 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: NYHA Class III Heart Failure
Interventions: Not listed
Lead sponsor: ImpediMed Limited; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Child Mental Disorders, Obesity, Metabolic Syndrome
Interventions: Behavioral Weight Loss, Diet and Exercise Education; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 6 Years to 18 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: NYHA Class III Heart Failure
Interventions: SOZO; Device
Lead sponsor: ImpediMed Limited; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Rochester, Minnesota • Lancaster, Pennsylvania

Conditions: Oral Hormonal Contraceptive Use, Neural Activity, Mood, Hedonic Function
Interventions: Levonorgestrel/ethinyl estradiol, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older · Female only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Neurofibromatosis 1, Neurofibroma, Plexiform
Interventions: Pirfenidone; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 3 Years to 21 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 15
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Chicago, Illinois + 12 more

Conditions: DIGEST, Evidence Based Measurement, Dysphagia, Randomized Implementation
Interventions: No intervention, DIGEST Training Program, DIGEST Training + Practice Facilitation; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Deep Venous Thrombosis
Interventions: Not listed
Lead sponsor: Diagnostica Stago; Industry
Eligibility: Up to 80 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Search by objective public record fields.

A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935

A Preliminary Study of Bone Density in Neonates

Measurement of the Radiation Dose Cuticles Using Electron Paramagnetic Resonance (EPR)

Development of Upper Limb Motor Scale to Measure Quality of Movement and Body Awareness in Stroke

Detection of Blood in the GI Lumen With HemoPill Acute

Non Contact Measurement of Vital Signs

Blood Flow and Pain Crises in People With Sickle Cell Disease

Development of a Patient-Reported Outcome Measure to Assess Recovery After Abdominal Surgery

Validation of a New Device to Measure Neuromuscular Disease Progression

Comparison of Standing Versus Supine 3D Cone Beam Computed Tomography in Patient With Obstructive Sleep Apnea

Portable Measurement of Protoporphyrin IX in the Skin

PRecision Integrated Saturation Monitor

Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During

Scan-Rescan Sub-Study of MS PATHS

Time Study for Biometry Measurements With the Lenstar and IntraOcularLens (IOL) Master 500

Salivary Diagnostic Testing for IVF

Evaluating Genes in Sputum to Measure Drug Response in COPD

Bioimpedance Spectroscopy Compared to CardioMEMS™

Healthy Bodies, Healthy Kids

Correlation of SOZO BIS Measures With CardioMEMS PA Pressure

Contraceptive Hormone and Reward Measurement (CHARM Study)

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis